Advancements in SELEX Technology for Aptamers and Emerging Applications in Therapeutics and Drug Delivery
Biomolecules · 05.06.2025 · 15 (6) · 818
DOI: 10.3390/biom15060818 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 05.06.2025. Verfasst von Liangjie Feng und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Sciences, Shanghai Institute of Technology, 100 Haiquan Road, Shanghai 201418, China. Hauptthemen laut MEDLINE: SELEX Aptamer Technique, Aptamers, Nucleotide, Drug Delivery Systems. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The project was sponsored by Shanghai Sailing Program, China, Collaborative innovation project of Shanghai Institute of Technology, Science and Technology Talent Development Fund for Young and Middle-aged Teachers of Shanghai Institute of Technology.
Abstract (Originalsprache)
Nucleic acid aptamers, selected through the Systematic Evolution of Ligands by Exponential Enrichment (SELEX), are short nucleic acid sequences that exhibit high affinity and specificity towards diverse targets. Over the past three decades, substantial advancements have been made in both the technology and applications of nucleic acid aptamers. This review provides an in-depth analysis of the historical development and defining characteristics of aptamers, highlighting recent technological innovations in SELEX, including Capillary Electrophoresis SELEX, Microfluidic SELEX, Cell-SELEX, and others. We explore the applications of aptamers in therapeutic and targeted drug delivery, emphasizing their advantages over traditional antibodies such as cost-effectiveness, ease of synthesis, and lower immunogenicity. Key challenges such as stability, specificity, and efficient delivery are discussed, with proposed strategies for improvement including advanced chemical modifications and integration with nanotechnology. By integrating advanced technologies, aptamers hold significant promise for enhancing precision medicine and personalized therapeutic interventions, offering new avenues for the treatment of complex diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Sciences, Shanghai Institute of Technology, 100 Haiquan Road, Shanghai 201418, China.
- Institute of Quality Standard and Testing Technology of BAAFS, Beijing 100097, China.
Förderung
- The project was sponsored by Shanghai Sailing Program, China
- Collaborative innovation project of Shanghai Institute of Technology
- Science and Technology Talent Development Fund for Young and Middle-aged Teachers of Shanghai Institute of Technology
- Shanghai Sailing Program, China
- AI-enabled discipline promotion plan of Shanghai, China
- Collaborative Innovation Project of the Shanghai Institute of Technology
Zitieren
APA
Feng, L., Sun, Y., Jia, W., Yu, Y., Liu, C., Yang, J., Luan, Y., Chen, J., & Wang, F. (2025). Advancements in SELEX Technology for Aptamers and Emerging Applications in Therapeutics and Drug Delivery. Biomolecules, 15(6), 818. https://doi.org/10.3390/biom15060818
Vancouver
Feng L, Sun Y, Jia W, Yu Y, Liu C, Yang J, et al. Advancements in SELEX Technology for Aptamers and Emerging Applications in Therapeutics and Drug Delivery. Biomolecules. 2025;15(6):818. doi:10.3390/biom15060818
BibTeX
@article{Feng2025,
author = {Feng, Liangjie and Sun, Yu and Jia, Wenshen and Yu, Yang and Liu, Chang and Yang, Jing and Luan, Yunxia and Chen, Jin and Wang, Fengchao},
title = {Advancements in SELEX Technology for Aptamers and Emerging Applications in Therapeutics and Drug Delivery},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {6},
pages = {818},
doi = {10.3390/biom15060818}
}
EUVIMED